A famous doctor: Corona will end and no second wave

0
106


A new surprise was sparked by the controversial doctor of France, Didier Raoul, declaring that the Coruna virus is about to end, ruling out the occurrence of second waves of the epidemic that toppled more than 300 thousand people around the world, despite the World Health Organization confirmed, on Wednesday, that the emerging virus may never disappear .

In a video posted a few days ago on his official account on Twitter, the doctor who heads the Infectious Diseases Department at Marseille Hospital in France, reaffirmed that the virus is significantly receding globally, expecting that new infections will not be recorded significantly, but rather the end of this crisis that afflicted the entire world.

He also stressed that all scientific data confirm that the virus is on the way to completion, adding that some cases will appear naturally here and there, but we will not see waves of outbreaks like the previous day, considering that the dynamism of the pandemic has declined significantly.

While a number of deaths due to Coffed 19 may continue to be recorded as a result of some severe cases.

As for the French city of Marseille, he also confirmed that Corona started ending in it, with an orphan case recorded last Monday, for example, although more than 1,200 people were tested, he said.

Controversial hydroxychloroquine

It is reported that Didier, who is considered one of the most demanding treatment of Corona patients with hydroxychloroquine, a drug that was previously given to malaria patients, had previously confirmed that the emerging virus that appeared in the Chinese city of Wuhan for the first time last December will end in the spring or early summer.

However, the French doctor has sparked widespread controversy in his country and internationally, in light of his adherence to this malaria drug, although some studies have indicated its ineffectiveness.

Disappointing results

In two recent studies published today, Friday, it was found that treatment of Covid-19 patients with malaria hydroxychloroquine had no positive effect and had caused other health complications.

In the first study, researchers from France monitored 181 hospital patients suffering from pneumonia due to corona and requiring oxygen.

84 of them were treated with hydroxychloroquine and the rest were not given the drug, but they found no significant difference between the outcomes of the two groups.

The authors of the study, published in the BMG magazine, said that “hydroxychloroquine is receiving global attention as a possible treatment for Covid-19 because of the positive results of small studies.”

“However, the results of this study do not support giving it to patients who have been hospitalized and who need oxygen,” they added.

A second study was also conducted in China, during which 150 patients with coronavirus were divided into two groups, one of which received hydroxychloroquine.

Four weeks later, tests revealed similar rates of infection in both groups, so that adverse reactions to treatment were more common in the group receiving the drug. Also, the severity or duration of symptoms did not differ between the two groups.

");
            //}, 3000);
        }
    });
    //$(window).bind('scroll ');
    $ (window) .scroll (function () {
        if (alreadyLoaded_facebookConnect == false) {
            alreadyLoaded_facebookConnect = true;
            // $ (window) .unbind ('scroll');
            // console.log ("scroll loaded");

            (function (d, s, id) {
                var js, fjs = d.getElementsByTagName (s)[0];
                if (d.getElementById (id)) return;
                js = d.createElement (s); js.id = id;
                js.async = true;
                js._https = true;
                js.src = "https://connect.facebook.net/en_US/all.js#xfbml=1&appId=148379388602322";
                fjs.parentNode.insertBefore (js, fjs);
            } (document, 'script', 'facebook-jssdk'));
            // pre_loader ();
            // $ (window) .unbind ('mousemove');
            // setTimeout (function () {
            // $ ('# boxTwitter'). html ("");
            //}, 3000);

            var scriptTag = document.createElement ("script");
            scriptTag.type = "text / javascript"
            scriptTag.src = "https://news.google.com/scripts/social.js";
            scriptTag.async = true;
            document.getElementsByTagName ("head")[0].appendChild (scriptTag);

            (function () {
                $ .getScript ("https://news.google.com/scripts/social.js", function () {});
        });

    }
    });

//$(window).load(function () {
// setTimeout (function () {
// // add the returned content to a newly created script tag
// var se = document.createElement ('script');
// se.type = "text / javascript";
// //se.async = true;
// se.text = "setTimeout (function () {pre_loader ();}, 5000);";
// document.getElementsByTagName ('body')[0].appendChild (se);
//}, 5000);
//});





LEAVE A REPLY

Please enter your comment!
Please enter your name here